Hydroxychavicol, a novel betel leaf component, inhibits platelet aggregation by suppression of cyclooxygenase, thromboxane production and calcium mobilization
Open accessThe DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Abstract
Background and purpose: Platelet hyperactivity is important in the pathogenesis of cardiovascular diseases. Betel leaf (PBL) is consumed by 200‐600 million betel quid chewers in the world. Hydroxychavicol (HC), a betel leaf component, was tested for its antiplatelet effect. Experimental approach: We tested the effect of HC on platelet aggregation, thromboxane B 2 (TXB 2) and reactive oxygen species (ROS) production, cyclooxygenase (COX) activity, ex vivo platelet aggregation and mouse bleeding time and platelet plug formation in vivo. The pharmacokinetics of HC in rats was also assessed. Key results: HC inhibited arachidonic acid (AA) and collagen‐induced platelet aggregation and TXB 2 production. HC inhibited the thrombin‐induced TXB 2 production, but not platelet aggregation. SQ29548, suppressed collagen‐ and thrombin‐induced TXB 2 production, but not thrombin‐induced platelet aggregation. HC also suppressed COX‐1/COX‐2 enzyme activity and the AA‐induced ROS production and Ca 2+ mobilization. HC further inhibited the ex vivo platelet aggregation of platelet‐rich plasma (>100 nmole/mouse) and prolonged platelet plug formation (>300 nmole/mouse) in mesenteric microvessels, but showed little effect on bleeding time in mouse tail. Moreover, pharmacokinetics analysis found that more than 99% of HC was metabolized within 3 min of administration in Sprague‐Dawley rats in vivo. Conclusions and implications: HC is a potent COX‐1/COX‐2 inhibitor, ROS scavenger and inhibits platelet calcium signaling, TXB 2 production and aggregation. HC could be a potential therapeutic agent for prevention and treatment of atherosclerosis and other cardiovascular diseases through its anti‐inflammatory and antiplatelet effects, without effects on haemostatic functions. British Journal of Pharmacology (2007) 152, 73–82; doi:10.1038/sj.bjp.0707367
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
The aggregation of blood platelets
Born, G. V. R., & Cross, M. J. (1963) · The Journal of Physiology · doi:10.1113/jphysiol.1963.sp007185 · Cited by 2,111
Reactive Oxygen Species: Players in the Platelet Game
Krötz, F., Sohn, H.-Y., & Pohl, U. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000145574.90840.7d · Cited by 1,006
Novel Clinical Markers of Vascular Wall Inflammation
Blake, G. J., & Ridker, P. M. (2001) · Circulation Research · doi:10.1161/hh2101.099270 · Cited by 754
Betel quid chewing, cigarette smoking and alcohol consumption related to oral cancer in Taiwan
Ko, Y., Huang, Y., Lee, C., Chen, M., Lin, L., & Tsai, C. (1995) · Journal of Oral Pathology & Medicine · doi:10.1111/j.1600-0714.1995.tb01132.x · Cited by 722
Self-citationBetel-quid and areca-nut chewing and some areca-nut derived nitrosamines.
(2004) · PubMed · Cited by 591
Jeng, J. H., Chang, M. C., & Hahn, L. J. (2001) · Oral Oncology · doi:10.1016/s1368-8375(01)00003-3 · Cited by 421
Self-citationBiphasic Kinetics of Activation and Signaling for PAR1 and PAR4 Thrombin Receptors in Platelets
Covic, L., Gresser, A. L., & Kuliopulos, A. (2000) · Biochemistry · doi:10.1021/bi9927078 · Cited by 306
Significance of testing platelet functions in vitro
HOLMSEN, H. (1994) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1994.tb02418.x · Cited by 297
Kinetic basis for selective inhibition of cyclo-oxygenases
Gierse, J. K., Koboldt, C. M., Walker, M. C., Seibert, K., & Isakson, P. C. (1999) · Biochemical Journal · doi:10.1042/0264-6021:3390607 · Cited by 287
Thromboregulation: multicellular modulation of platelet reactivity in hemostasis and thrombosis
Marcus, A. J., & Safier, L. B. (1993) · The FASEB Journal · doi:10.1096/fasebj.7.6.8472890 · Cited by 273
NAD(P)H oxidase–dependent platelet superoxide anion release increases platelet recruitment
Krötz, F., Sohn, H. Y., Gloe, T., Zahler, S., Riexinger, T., Schiele, T. M., Becker, B. F., Theisen, K., Klauss, V., & Pohl, U. (2002) · Blood · doi:10.1182/blood.v100.3.917 · Cited by 262
Oxygen Free Radicals and Platelet Activation
Iuliano, L., Colavita, A. R., Leo, R., Praticò, D., & Violi, F. (1997) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(96)00488-1 · Cited by 236
(1993) · Laboratory Animals · doi:10.1258/002367793781082412 · Cited by 231
Platelets and cardiovascular disease
Willoughby, S. (2002) · European Journal of Cardiovascular Nursing · doi:10.1016/s1474-5151(02)00038-5 · Cited by 205
Areca nut use: an independent risk factor for oral cancer: The health problem is under-recognised
Warnakulasuriya, S., Trivedy, C., & Peters, T. J. (2002) · BMJ · doi:10.1136/bmj.324.7341.799 · Cited by 181
Morton, D. B., Jennings, M., Batchelor, G. R., Bell, D. J., Birke, L. I. A., Davies, K., Eveleigh, J. R., Gunn, D., Heath, M. F., Howard, B., et al. (1993) · Laboratory Animals · doi:10.1258/002367793780745633 · Cited by 179
Kato, M., Nishida, S., Kitasato, H., Sakata, N., & Kawai, S. (2001) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357011778070 · Cited by 163
Miller, C. C., Hale, P., & Pentland, A. P. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)41895-3 · Cited by 145
Runnie, I., Salleh, M. N., Mohamed, S., Head, R. J., & Abeywardena, M. Y. (2004) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2004.03.019 · Cited by 141
Removal of blood from laboratory mammals and birds
Evans, G. O. (1994) · Laboratory Animals · doi:10.1258/002367794780745209 · Cited by 126
Aggregin: a platelet ADP receptor that mediates activation
Colman, R. W. (1990) · The FASEB Journal · doi:10.1096/fasebj.4.5.2407587 · Cited by 123
Hydroxychavicol: A new phenolic antimutagen from betel leaf
Amonkar, A. J., Nagabhushan, M., D'Souza, A. V., & Bhide, S. V. (1986) · Food and Chemical Toxicology · doi:10.1016/0278-6915(86)90065-7 · Cited by 114
Salleh, M. N., Runnie, I., Roach, P. D., Mohamed, S., & Abeywardena, M. Y. (2002) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf011593f · Cited by 104
Correlation of mutagenicity and tumorigenicity of betel quid and its ingredients
Shirname, L. P., Menon, M. M., Nair, J., & Bhide, S. V. (1983) · Nutrition and Cancer · doi:10.1080/01635588309513783 · Cited by 100
Chang, M. C., Uang, B. J., Wu, H. L., Lee, J. J., Hahn, L. J., & Jeng, J. H. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704492 · Cited by 99 · cited 10×
“HC, which shows structural similarity to eugenol, has antioxidative, antimutagenic, anticarcinogenic, as well as chemopreventive effects (Amonkar et al., 1986, 1989; Chang et al., 2002).”
BackgroundMethodSelf-citationHuss, U., Ringbom, T., Perera, P., Bohlin, L., & Vasänge, M. (2002) · Journal of Natural Products · doi:10.1021/np020023m · Cited by 96
Role of hydroxyl radicals in the activation of human platelets
IULIANO, L., PEDERSEN, J. Z., PRATICÒ, D., ROTILIO, G., & VIOLI, F. (1994) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1994.tb18782.x · Cited by 95
Free radical-mediated platelet activation by hemoglobin released from red blood cells
Iuliano, L., Violi, F., Pedersen, J. Z., Praticò, D., Rotilio, G., & BALSANO, F. (1992) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(92)90267-z · Cited by 85
Mannan, N., Boucher, B. J., & Evans, S. J. W. (2000) · British Journal of Nutrition · doi:10.1017/s0007114500000349 · Cited by 84
Hydrogen peroxide release from human blood platelets
Finazzi‐Agrò, A., Menichelli, A., Persiani, M., Biancini, G., & Principe, D. D. (1982) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(82)90004-6 · Cited by 76
Rao, A. R. (1984) · International Journal of Cancer · doi:10.1002/ijc.2910330506 · Cited by 70
Li, N., Hu, H., & Hjemdahl, P. (2003) · Thrombosis Research · doi:10.1016/j.thromres.2003.08.026 · Cited by 67
Chang, M., Lin, H., Peng, H.-C., et al. (1998) · Blood · doi:10.1182/blood.v91.5.1582 · Cited by 66
Self-citationJeng, J., Wu, H.-L., Lin, B., et al. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.05.023 · Cited by 66
Self-citationJeng, J., Chen, S.-Y., Liao, C., Tung, Y.-Y., Lin, B., Hahn, L., & Chang, M. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00749-9 · Cited by 62
Self-citationRosado, J. A. (2002) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(02)00161-5 · Cited by 56
Reactive oxygen species are crucial for hydroxychavicol toxicity toward KB epithelial cells
Jeng, J., Wang, Y.-J., Chang, W. H., Wu, H. L., Li, C., Uang, B. J., Kang, J., Lee, J., Hahn, L. J., Lin, B., et al. (2004) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-003-3272-8 · Cited by 56
Self-citationA study of aspirin and clopidogrel in idiopathic pulmonary arterial hypertension
Robbins, I. M., Kawut, S. M., Yung, D., Reilly, M. P., Lloyd, W., Cunningham, G., Loscalzo, J., Kimmel, S. E., Christman, B. W., & Barst, R. J. (2006) · European Respiratory Journal · doi:10.1183/09031936.06.00095705 · Cited by 55
Amonkar, A. J., Padma, P. R., & Bhide, S. V. (1989) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/0027-5107(89)90085-7 · Cited by 53
Antiplatelet and calcium inhibitory properties of eugenol and sodium eugenol acetate
Chen, S.-J., Wang, M.-H., & Chen, I. (1996) · General Pharmacology The Vascular System · doi:10.1016/0306-3623(95)02089-6 · Cited by 53
Triterpenes and B-sitosterol from piper betle: isolation, antiplatelet and anti-inflammatory effects
Saeed, S. A., Farnaz, S., SIMJEE, R. U., & Malik, A. M. (1993) · Biochemical Society Transactions · doi:10.1042/bst021462s · Cited by 52
Stimulus–Response Coupling Mechanisms
Huang, E. M., & Detwiler, T. C. (1986) · Elsevier eBooks · doi:10.1016/b978-0-12-553240-2.50005-1 · Cited by 48
Chiu, Y., Wu, S., Tseng, C.-D., Yen, M., & Chen, T. H.-H. (2006) · Journal of Hypertension · doi:10.1097/01.hjh.0000222750.82820.19 · Cited by 43
HYPERACTIVITY AND INCREASED HYDROGEN PEROXIDE FORMATION IN PLATELETS OF NIDDM PATIENTS
Leoncini, G., Signorello, M. G., Piana, A., Carrubba, M., & Armani, U. (1997) · Thrombosis Research · doi:10.1016/s0049-3848(97)00058-3 · Cited by 43
Padma, P. R., Amonkar, A. J., & Bhide, S. V. (1989) · Mutagenesis · doi:10.1093/mutage/4.2.154 · Cited by 43
Hydroxychavicol: a new anti-nitrosating phenolic compound from betel leaf
Nagabhushan, M., Amonkar, A. J., Nair, U. J., D'Souza, A. V., & Bhide, S. V. (1989) · Mutagenesis · doi:10.1093/mutage/4.3.200 · Cited by 39
Hornberger, W., & Patscheke, H. (1990) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1990.tb15292.x · Cited by 34
Inhibition of Lipoxygenase by Phenolic compounds.
Dohi, T., ANAMURA, S., Shirakawa, M., et al. (1991) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.55.547 · Cited by 28
Kariyazono, H., Nakamura, K., Arima, J., et al. (2004) · Blood Coagulation & Fibrinolysis · doi:10.1097/00001721-200403000-00007 · Cited by 28
Rotondo, S., Krauze-Brzósko, K., Manarini, S., Evangelista, V., & Cerletti, C. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.02.006 · Cited by 27
Platelet Aggregation in Whole Blood: The Role of Thromboxane A2 and Adenosine Diphosphate
Carter, A. J., & Heptinstall, S. (1985) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1660081 · Cited by 22
Maurice, P., Legrand, C., & Fauvel‐Lafeve, F. (2004) · The FASEB Journal · doi:10.1096/fj.03-1151com · Cited by 20
Fogari, R., & Zoppi, A. (2005) · American Journal of Cardiovascular Drugs · doi:10.2165/00129784-200505040-00001 · Cited by 16
Chang, M., & Huang, T. (1994) · Thrombosis Research · doi:10.1016/0049-3848(94)90051-5 · Cited by 16
Self-citationLahiri, M., & Bhide, S. V. (1993) · Cancer Letters · doi:10.1016/0304-3835(93)90185-c · Cited by 16
Yamada, K., Shuto, K., & Nakamizo, N. (1983) · Thrombosis Research · doi:10.1016/0049-3848(83)90141-x · Cited by 6
Research works printed but not linked: 4
- Gierse JK, 1999, Kinetic basis for selective inhibition of cyclooxygenases, Biochem J, 339, 607, 10.1042/bj3390607 · doi:10.1042/bj3390607 · Paper page
- Huang LS, 1993, Phenolic compounds of piper betle flower as flavoring and neuronal activity modulating agents, Phenolic Compounds in Food and their Effects on Health I: Analysis, Occurrence and Chemistry
- IARC, 2004, IARC Monographs
- TsaiCC(2003).The association between areca/betel quid chewing cigarette smoking alcohol drinking and asthma heart disease and peptic ulcer in Taiwan. Master thesis Kaohsiung Medical University.
Cited by
In vitro antifungal activity of hydroxychavicol isolated from Piper betle L
Ali, I., Khan, F. G., Suri, K. A., Gupta, B. D., Satti, N. K., Dutt, P., Afrin, F., Qazi, G. N., & Khan, I. A. (2010) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/1476-0711-9-7 · Cited by 176
Metadata
- Authors
- Chang, M. C., Uang, B. J., Tsai, C. Y., Wu, H. L., Lin, B. R., Lee, C. S., Chen, Y. J., Chang, C. H., Tsai, Y. L., Kao, C. J., & Jeng, J. H.
- Affiliations
- National Tsing Hua University (TW)
- Development Center for Biotechnology (TW)
- National Taiwan University Hospital (TW)
- National Taiwan University (TW)
- Corresponding author
- Jeng, J H
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2007-09
- Volume
- 152
- Issue
- 1
- Pages
- 73-82
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- PMC
- PMC1978281
- OpenAlex
- W1980926937
- Cited by
- 58
- References
- 57
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 2 · 2023: 3 · 2022: 7 · 2021: 3 · 2019: 5 · 2018: 5 · 2017: 2 · 2016: 2 · 2015: 2 · 2014: 8 · 2013: 2 · 2012: 4
- FWCI
- 1.49
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- British Journal of Pharmacology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Science Council
- Chang Gung Medical Foundation
- Topics
- Health Sciences › Medicine › Hematology › Platelet Disorders and Treatments
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Antiplatelet Therapy and Cardiovascular Diseases
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Keywords
- hydroxychavicol, betel leaf, antiplatelet activity, platelet aggregation, cyclooxygenase inhibition, thromboxane B2, reactive oxygen species, calcium mobilization, arachidonic acid, collagen-induced aggregation, thrombin-induced aggregation, pharmacokinetics, atherosclerosis, cardiovascular disease, SQ29548
- MeSH terms
- Animals, Bleeding Time, Blood Platelets, Collagen, Dose-Response Relationship, Drug, Eugenol, Male, Mice, Inbred ICR, Platelet Aggregation, Platelet Aggregation Inhibitors, Rabbits, Thrombin, Thromboxane B2, Arachidonic Acid, Cyclooxygenase Inhibitors, Rats, Sprague-Dawley, Reactive Oxygen Species, Plant Leaves, Calcium Signaling, Piper betle, Mice, Rats, Cyclooxygenase 1, Cyclooxygenase 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.